Warby Parker
American eyeglasses and contact lens retailer
WRBY NYSE
SEC CIK 1504776
Follow Warby Parker
Weekly email: filings, results
Revenue, last quarter
$244.7M
+10.4% vs same quarter last year
Net income
$5.6M
−4.6% vs same quarter last year
EPS, diluted
$0.04
−20% vs same quarter last year
Operating cash flow
$24.7M
+37.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $871.9M | $1.6M |
| FY24 | $771.3M | −$20.4M |
| FY23 | $669.8M | −$63.2M |
| FY22 | $598.1M | −$110.4M |
| FY21 | $540.8M | −$144.3M |
| FY20 | $393.7M | −$55.9M |
| FY19 | $370.5M | $0 |
| FY18 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 54% | −0.6% | 0.2% |
| FY24 | 55.3% | −3.9% | −2.6% |
| FY23 | 54.5% | −10.7% | −9.4% |
| FY22 | 57% | −18.6% | −18.5% |
| FY21 | 58.8% | −26.6% | −26.7% |
| FY20 | 58.9% | −14.1% | −14.2% |
| FY19 | 60.2% | −0.4% | 0% |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $43.7M |
| FY24 | $34.7M |
| FY23 | $7.3M |
| FY22 | −$49.8M |
| FY21 | −$80.5M |
| FY20 | $12.7M |
| FY19 | −$11.2M |
| FY18 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | $0 |
| FY22 | $0 |
| FY21 | $8.1M |
| FY20 | $0 |
| FY19 | $79.5M |
| FY18 | - |
- Warby Parker
- Healthcare median
Show the numbers
| Year | Warby Parker | Healthcare median |
|---|---|---|
| FY25 | 0.2% | −30.6% |
| FY24 | −2.6% | −47% |
| FY23 | −9.4% | −58% |
| FY22 | −18.5% | −80.4% |
| FY21 | −26.7% | −71.9% |
| FY20 | −14.2% | −62.2% |
| FY19 | 0% | −46.3% |
| FY18 | - | −49.6% |